Skip to content
PICO Portalanswers from OpenAlex

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

PaperCitations, authors & open-access status

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis have?

PICO Portalcitation count

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis has 41 citations in the OpenAlex counts PICO Portal stores.

When was Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis published?

PICO Portalyear

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis has 2023 year in the PICO Portal index.

What is the open-access status of Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis?

PICO Portaloa status

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis has hybrid oa status in the PICO Portal index.

What is the DOI of Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis?

PICO Portaldoi

The DOI for Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis is on the source record.

What is the PMID of Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis?

PICO Portalpmid

The PMID for Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis is on the source record.

What is the OpenAlex record for Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis?

PICO Portalopenalex

The OpenAlex for Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial